- Home
- Pangia Robert W
Insider Trading History of Pangia Robert W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pangia Robert W since 2006.
The trader's CIK number is 1236188.
At the time of the last reporting, Pangia Robert W was the 10% Owner of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
Note that in the past
PANGIA ROBERT W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Icos Corp / De (ICOS) by Pangia Robert W
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | ICOS | 0 | $0 | 17,778 | $435,987 | 17,778 | $140,001 |
Yearly summary of insider trading at Biogen Inc. (BIIB) by Pangia Robert W
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | BIIB | 0 | $0 | 6,114 | $2,008,754 | 6,114 | $319,273 |
2018 | BIIB | 0 | $0 | 5,832 | $1,922,518 | 5,832 | $337,264 |
2017 | BIIB | 0 | $0 | 5,450 | $1,609,875 | 5,450 | $284,599 |
2015 | BIIB | 0 | $0 | 3,625 | $1,497,958 | 3,625 | $179,818 |
2014 | BIIB | 0 | $0 | 12,500 | $3,665,312 | 12,500 | $594,374 |
2013 | BIIB | 0 | $0 | 8,400 | $1,813,532 | 2,500 | $165,725 |
2012 | BIIB | 0 | $0 | 27,500 | $3,775,000 | 27,500 | $1,299,600 |
2011 | BIIB | 0 | $0 | 15,000 | $1,399,035 | 15,000 | $768,675 |
2010 | BIIB | 0 | $0 | 15,000 | $960,000 | 15,000 | $888,750 |
2009 | BIIB | 0 | $0 | 30,000 | $1,562,220 | 30,000 | $932,490 |
2008 | BIIB | 0 | $0 | 30,000 | $1,931,905 | 30,000 | $233,730 |
2006 | BIIB | 0 | $0 | 0 | $0 | 1,250 | $0 |
Yearly summary of insider trading at Regen Biologics Inc (RGBO) by Pangia Robert W
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | RGBO | 285,715 | $1,000,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mcafee, Inc. (MFE) by Pangia Robert W
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | MFE | 0 | $0 | 172,641 | $8,165,919 | 172,641 | $4,271,828 |
2009 | MFE | 0 | $0 | 25,000 | $1,068,800 | 25,000 | $197,500 |
Insider trading activities at 4 companies by Pangia Robert W:
1. Icos Corp / De (ICOS)
2. Biogen Inc. (BIIB)
3. Regen Biologics Inc (RGBO)
4. Mcafee, Inc. (MFE)
Table 1. Insider trading of Icos Corp / De (ICOS) by Pangia Robert W
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-02-23 | ICOS | Sale | 17,778 | 24.52 | 435,987 |
2006-02-23 | ICOS | Option Ex | 17,778 | 7.88 | 140,001 |
Table 2. Insider trading of Biogen Inc. (BIIB) by Pangia Robert W
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-03-18 | BIIB | Option Ex | 6,114 | 52.22 | 319,273 |
2019-03-18 | BIIB | Sale | 6,114 | 328.55 | 2,008,754 |
2018-01-09 | BIIB | Option Ex | 5,832 | 57.83 | 337,264 |
2018-01-09 | BIIB | Sale | 5,832 | 329.65 | 1,922,518 |
2017-01-09 | BIIB | Option Ex | 5,450 | 52.22 | 284,599 |
2017-01-09 | BIIB | Sale | 5,450 | 295.39 | 1,609,875 |
2015-03-10 | BIIB | Sale | 3,625 | 413.23 | 1,497,958 |
2015-03-10 | BIIB | Option Ex | 3,625 | 49.60 | 179,818 |
2014-04-01 | BIIB | Option Ex | 6,250 | 47.55 | 297,187 |
2014-04-01 | BIIB | Sale | 6,250 | 308.42 | 1,927,625 |
2014-01-06 | BIIB | Option Ex | 6,250 | 47.55 | 297,187 |
2014-01-06 | BIIB | Sale | 6,250 | 278.03 | 1,737,687 |
2013-05-28 | BIIB | Sale | 5,900 | 237.23 | 1,399,657 |
2013-02-06 | BIIB | Option Ex | 2,500 | 66.29 | 165,725 |
2013-02-06 | BIIB | Sale | 2,500 | 165.55 | 413,875 |
2012-09-17 | BIIB | Option Ex | 5,000 | 66.29 | 331,450 |
2012-09-17 | BIIB | Sale | 5,000 | 155.00 | 775,000 |
2012-09-06 | BIIB | Sale | 5,000 | 150.00 | 750,000 |
2012-09-06 | BIIB | Option Ex | 5,000 | 66.29 | 331,450 |
2012-06-15 | BIIB | Option Ex | 5,000 | 36.94 | 184,700 |
2012-06-15 | BIIB | Sale | 5,000 | 140.00 | 700,000 |
2012-06-04 | BIIB | Sale | 5,000 | 130.00 | 650,000 |
2012-06-04 | BIIB | Option Ex | 5,000 | 36.94 | 184,700 |
2012-03-08 | BIIB | Option Ex | 7,500 | 35.64 | 267,300 |
2012-03-08 | BIIB | Sale | 7,500 | 120.00 | 900,000 |
2011-05-26 | BIIB | Option Ex | 15,000 | 51.24 | 768,675 |
2011-05-26 | BIIB | Sale | 15,000 | 93.27 | 1,399,035 |
2010-10-28 | BIIB | Sale | 15,000 | 64.00 | 960,000 |
2010-10-28 | BIIB | Option Ex | 15,000 | 59.25 | 888,750 |
2009-12-24 | BIIB | Sale | 15,000 | 52.15 | 782,220 |
2009-12-24 | BIIB | Option Ex | 15,000 | 31.08 | 466,245 |
2009-09-29 | BIIB | Sale | 15,000 | 52.00 | 780,000 |
2009-09-29 | BIIB | Option Ex | 15,000 | 31.08 | 466,245 |
2008-04-08 | BIIB | Sale | 11,000 | 64.72 | 711,953 |
2008-04-08 | BIIB | Sale | 19,000 | 64.21 | 1,219,952 |
2008-04-08 | BIIB | Option Ex | 30,000 | 7.79 | 233,730 |
2006-05-25 | BIIB | Option Ex | 1,250 | .00 | 0 |
Table 3. Insider trading of Regen Biologics Inc (RGBO) by Pangia Robert W
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-01-16 | RGBO | Buy | 285,715 | 3.50 | 1,000,002 |
Table 4. Insider trading of Mcafee, Inc. (MFE) by Pangia Robert W
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-11-09 | MFE | Sale | 172,641 | 47.30 | 8,165,919 |
2010-11-09 | MFE | Option Ex | 172,641 | 24.74 | 4,271,828 |
2009-08-12 | MFE | Sale | 5,000 | 43.25 | 216,250 |
2009-08-11 | MFE | Sale | 10,000 | 42.75 | 427,500 |
2009-08-12 | MFE | Option Ex | 5,000 | 7.90 | 39,500 |
2009-08-10 | MFE | Sale | 10,000 | 42.51 | 425,050 |
2009-08-10 | MFE | Option Ex | 10,000 | 7.90 | 79,000 |
2009-08-11 | MFE | Option Ex | 10,000 | 7.90 | 79,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pangia Robert W
(10% Owner of Biogen Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.